IVA cloning: A single-tube universal cloning system exploiting bacterial In Vivo Assembly.

Sci Rep

Neurobiology Division, MRC Laboratory of Molecular Biology, Cambridge, CB2 0QH, UK.

Published: June 2016


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

In vivo homologous recombination holds the potential for optimal molecular cloning, however, current strategies require specialised bacterial strains or laborious protocols. Here, we exploit a recA-independent recombination pathway, present in widespread laboratory E.coli strains, to develop IVA (In Vivo Assembly) cloning. This system eliminates the need for enzymatic assembly and reduces all molecular cloning procedures to a single-tube, single-step PCR, performed in <2 hours from setup to transformation. Unlike other methods, IVA is a complete system, and offers significant advantages over alternative methods for all cloning procedures (insertions, deletions, site-directed mutagenesis and sub-cloning). Significantly, IVA allows unprecedented simplification of complex cloning procedures: five simultaneous modifications of any kind, multi-fragment assembly and library construction are performed in approximately half the time of current protocols, still in a single-step fashion. This system is efficient, seamless and sequence-independent, and requires no special kits, enzymes or proprietary bacteria, which will allow its immediate adoption by the academic and industrial molecular biology community.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893743PMC
http://dx.doi.org/10.1038/srep27459DOI Listing

Publication Analysis

Top Keywords

cloning system
8
vivo assembly
8
molecular cloning
8
iva cloning
4
cloning single-tube
4
single-tube universal
4
cloning
4
universal cloning
4
system exploiting
4
exploiting bacterial
4

Similar Publications

The effects of apigenin, a plant flavonoid, were investigated using the two-electrode voltage-clamp technique on the function of the cloned α7 subunit of the human nicotinic acetylcholine (α7-nACh) receptor expressed in oocytes. Currents induced by ACh (100 μM) were reversibly potentiated by apigenin with an EC value of 5.4 µM in a voltage-independent manner.

View Article and Find Full Text PDF

bacteria exhibit a range of relationships with aphids. They may be co-obligate mutualists, commensals, or even pathogens depending on the strain, aphid host species, and environment. CWBI-2.

View Article and Find Full Text PDF

Introduction: Galectin-9 is a β-galactoside-binding lectin that functions as a critical pattern recognition receptor (PRR) in the host immune system, initiating immune defense responses by recognizing and binding to pathogen-associated molecular patterns (PAMPs) on the surface of microorganisms. In this study, we identified and characterized a novel galectin-9 cDNA, designated CcGal-9, from Yellow River carp ().

Methods: The full-length CcGal-9 cDNA was cloned and sequenced, and its structural features were analyzed.

View Article and Find Full Text PDF

Introduction: Ovarian cancer (OC) is a common malignant tumor of the female reproductive system and is usually found at an advanced stage. However, the treatment of OC with conventional the efficacy of surgery and chemotherapy is limited. Brusatol (BRU) is a unique nuclear factor erythroid 2-related factor 2 (Nrf2) pathway inhibitor with significant anti-cancer effects.

View Article and Find Full Text PDF

Autoimmune diseases (AIDs) constitute a group of disorders where the immune system mistakenly attacks the body's tissues. The pathogenesis of AIDs involve a breakdown in immune tolerance, culminating in an immune response that targets autoantigens. In adaptive immunity, secondary rearrangement of T cell receptors (TCRs) and B cell receptors (BCRs) involves sequential V(D)J recombination events during lymphocyte development.

View Article and Find Full Text PDF